Revolution Medicines · 1 month ago
Executive Director, Clinical Operations
Redwood City, California, United States
Full-time
Onsite
Director/Executive
$256K/yr - $320K/yr
15+ years expRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Executive Director of Clinical Operations will lead and manage clinical operations, ensuring the successful execution of clinical trials and fostering collaboration across teams while maintaining high standards of quality and efficiency.
Health CareLife ScienceMedical
Responsibilities
Mentors and represent Clinical Operations Study Teams view with clinical vendor outsourcing leaders to synergize strategy, including building efficiencies, collaboration with internal and external stakeholders
Shapes clinical operations infrastructure, to support high quality, efficient conduct and inspection ready clinical trials including but not limited to: Staff development tools, clinical processes alignment and standardization, inspection ready clinical document management processes, and other systems
Identifies gaps, aligns building of solutions and drives the evaluation, selection, deployment, and oversight of clinical operational resolutions
Identifies and builds achievable standards that allow for consistent oversight and content management of clinical operations systems such as but not limited to eTMF, Feasibility Work, LMS, Medical CRM, CTMS
Oversees Clinical Operations resource planning tracking and general strategy by partnering with RevMed management and appropriate fellow Clinical Operations and Functional Team to support clinical study execution
Leads Clinical Operations teams and builds partnerships with cross functional operations to ensure quality, timely and fiscally responsible deliverables across the RevMed portfolio
Cultivates collaborations with other functional groups to produce mutually beneficial, purposeful and operational objectives, deliverables, and creative solutions that meet current Global Industry ICH/GCP standards
Is a RevMed resource for Clinical Operations Systems, and actively forecasts plus acts to ensure Clinical Development plan/ programs meet RevMed goal
As requested, may cross over into leading study functions and/or assume leadership responsibilities beyond mentorships
Leads and grows Clinical Operations function and staff with a culture of respect, honesty, curiosity, empowerment and accountability for the achievement of their commitments and goals (company and personnel)
Qualification
Required
BS/MS Degree in a scientific discipline with a minimum of 15 years of clinical operations experience in the pharmaceutical or biotech industry, preferably the majority in oncology drug development
Minimum of 10 years clinical operations systems project and line management experience
Extensive experience in leading and managing global phase 1-3 clinical trials within designated timelines, resources, and budgets and translating the experiences into operational systems
A demonstrable record of strong leadership and teamwork
Extensive experience in selection of CROs/ vendors and management of external resources
Must have a working knowledge of data management, data review and analysis, and drug safety, pharmacovigilance and other related functions related to clinical trial conduct
Strong working knowledge of FDA Regulations, ICH Guidelines and GCPs governing the conduct of clinical trials
Thrives in a collaborative team setting and is driven by a desire to deploy innovative approaches and technologies in a high-energy environment
Excellent written and verbal communication skills
Ability to act as an excellent ambassador for Revolution Medicines in interactions with key opinion leaders, scientific advisors, corporate partners and, where necessary, investors
Demonstrated ability to multi-task, prioritize options, anticipate challenges, and execute goals as a member of an interdisciplinary team is extremely important
Preferred
Experience in working with cooperative group studies and investigator sponsored trials preferred
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
501-1000 employees
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase